Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge

References

• Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36 - 44; http://dx.doi.org/10.1016/S1473-3099(11)70295-X; PMID: 22032844
   PubMed Web of Science ®Google Scholar
• Girard MP, Katz JM, Pervikov Y, Hombach J, Tam JS. Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011. Vaccine 2011; 29:7579 - 86; http://dx.doi.org/10.1016/j.vaccine.2011.08.031; PMID: 21856358
   PubMedGoogle Scholar
• Hoa LK, Hiep LV, Be LV. Development of pandemic influenza vaccine production capacity in Viet Nam. Vaccine 2011; 29:Suppl 1 A34 - 6; http://dx.doi.org/10.1016/j.vaccine.2011.04.118; PMID: 21684426
   PubMedGoogle Scholar
• Stephenson I, Gust I, Pervikov Y, Kieny MP. Development of vaccines against influenza H5. Lancet Infect Dis 2006; 6:458 - 60; http://dx.doi.org/10.1016/S1473-3099(06)70528-X; PMID: 16870521
   PubMed Web of Science ®Google Scholar
• Dormitzer PR, Suphaphiphat P, Gibson DG, Wentworth DE, Stockwell TB, Algire MA, Alperovich N, Barro M, Brown DM, Craig S, et al. Synthetic generation of influenza vaccine viruses for rapid response to pandemics. Sci Transl Med 2013; 5:85ra68; http://dx.doi.org/10.1126/scitranslmed.3006368; PMID: 23677594
   PubMed Web of Science ®Google Scholar
• Frey S, Vesikari T, Szymczakiewicz-Multanowska A, Lattanzi M, Izu A, Groth N, Holmes S. Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults. Clin Infect Dis 2010; 51:997 - 1004; http://dx.doi.org/10.1086/656578; PMID: 20868284
   PubMed Web of Science ®Google Scholar
• Extance A. Cell-based flu vaccines ready for US prime time. Nat Rev Drug Discov 2011; 10:246; http://dx.doi.org/10.1038/nrd3414; PMID: 21455223
   PubMed Web of Science ®Google Scholar
• Jung EJ, Lee KH, Seong BL. Reverse genetic platform for inactivated and live-attenuated influenza vaccine. Exp Mol Med 2010; 42:116 - 21; http://dx.doi.org/10.3858/emm.2010.42.2.013; PMID: 20054235
   PubMed Web of Science ®Google Scholar
• Tseng YF, Hu AY, Huang ML, Yeh WZ, Weng TC, Chen YS, Chong P, Lee MS. Adaptation of high-growth influenza H5N1 vaccine virus in Vero cells: implications for pandemic preparedness. PLoS One 2011; 6:e24057; http://dx.doi.org/10.1371/journal.pone.0024057; PMID: 22022351
   PubMed Web of Science ®Google Scholar
• Ng SK. Current cell-based influenza vaccine production technology as pandemic contingency. Hum Vaccin Immunother 2012; 8:267 - 71; http://dx.doi.org/10.4161/hv.18336; PMID: 22426381
   PubMed Web of Science ®Google Scholar
• Boslego J. Influenza Vaccine Strategies for Broad Global Access. PATH Publications, 2007.
   Google Scholar
• Collin N, de Radiguès X, World Health Organization H1N1 Vaccine Task Force. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine 2009; 27:5184 - 6; http://dx.doi.org/10.1016/j.vaccine.2009.06.034; PMID: 19563891
   PubMed Web of Science ®Google Scholar
• Pandey A, Singh N, Sambhara S, Mittal SK. Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses. Hum Vaccin 2010; 6:178 - 88; http://dx.doi.org/10.4161/hv.6.2.9899; PMID: 19875936
   PubMed Web of Science ®Google Scholar
• Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013; 368:1888 - 97; http://dx.doi.org/10.1056/NEJMoa1304459; PMID: 23577628
   PubMed Web of Science ®Google Scholar
• Treanor JJ, El Sahly H, King J, Graham I, Izikson R, Kohberger R, Patriarca P, Cox M. Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial. Vaccine 2011; 29:7733 - 9; http://dx.doi.org/10.1016/j.vaccine.2011.07.128; PMID: 21835220
   PubMed Web of Science ®Google Scholar
• Cox MM, Hashimoto Y. A fast track influenza virus vaccine produced in insect cells. J Invertebr Pathol 2011; 107:Suppl S31 - 41; http://dx.doi.org/10.1016/j.jip.2011.05.003; PMID: 21784229
   PubMed Web of Science ®Google Scholar
• Khurana S, Verma S, Verma N, Crevar CJ, Carter DM, Manischewitz J, King LR, Ross TM, Golding H. Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets. J Virol 2011; 85:1246 - 56; http://dx.doi.org/10.1128/JVI.02107-10; PMID: 21084473
   PubMed Web of Science ®Google Scholar
• Shoji Y, Farrance CE, Bautista J, Bi H, Musiychuk K, Horsey A, Park H, Jaje J, Green BJ, Shamloul M, et al. A plant-based system for rapid production of influenza vaccine antigens. Influenza Other Respir Viruses 2012; 6:204 - 10; http://dx.doi.org/10.1111/j.1750-2659.2011.00295.x; PMID: 21974811
   PubMed Web of Science ®Google Scholar
• Mortimer E, Maclean JMJ, Mbewana S, Buys A, Williamson ALA, Hitzeroth III, Rybicki EPE. Setting up a platform for plant-based influenza virus vaccine production in South Africa. BMC Biotechnol 2012; 12:14; http://dx.doi.org/10.1186/1472-6750-12-14; PMID: 22536810
   PubMed Web of Science ®Google Scholar
• D’Aoust MA, Lavoie PO, Couture MM, Trépanier S, Guay JM, Dargis M, Mongrand S, Landry N, Ward BJ, Vézina LP. Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnol J 2008; 6:930 - 40; http://dx.doi.org/10.1111/j.1467-7652.2008.00384.x; PMID: 19076615
   PubMed Web of Science ®Google Scholar
• Tretyakova I, Pearce MB, Florese R, Tumpey TM, Pushko P. Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses. Virology 2013; 442:67 - 73; http://dx.doi.org/10.1016/j.virol.2013.03.027; PMID: 23618102
   PubMed Web of Science ®Google Scholar
• Landry N, Ward BJ, Trépanier S, Montomoli E, Dargis M, Lapini G, Vézina LP. Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS One 2010; 5:e15559; http://dx.doi.org/10.1371/journal.pone.0015559; PMID: 21203523
   PubMed Web of Science ®Google Scholar
• Chichester JA, Jones RM, Green BJ, Stow M, Miao F, Moonsammy G, Streatfield SJ, Yusibov V. Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: a phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in healthy adults. Viruses 2012; 4:3227 - 44; http://dx.doi.org/10.3390/v4113227; PMID: 23202523
   PubMed Web of Science ®Google Scholar
• McCormick AA, Corbo TA, Wykoff-Clary S, Nguyen LV, Smith ML, Palmer KE, Pogue GP. TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models. Vaccine 2006; 24:6414 - 23; http://dx.doi.org/10.1016/j.vaccine.2006.06.003; PMID: 16860441
   PubMed Web of Science ®Google Scholar
• McCormick AA, Corbo TA, Wykoff-Clary S, Palmer KE, Pogue GP. Chemical conjugate TMV-peptide bivalent fusion vaccines improve cellular immunity and tumor protection. Bioconjug Chem 2006; 17:1330 - 8; http://dx.doi.org/10.1021/bc060124m; PMID: 16984144
   PubMed Web of Science ®Google Scholar
• McCormick AA, Palmer KE. Genetically engineered Tobacco mosaic virus as nanoparticle vaccines. Expert Rev Vaccines 2008; 7:33 - 41; http://dx.doi.org/10.1586/14760584.7.1.33; PMID: 18251692
   PubMed Web of Science ®Google Scholar
• Smith ML, Fitzmaurice WP, Turpen TH, Palmer KE. Display of peptides on the surface of tobacco mosaic virus particles. Curr Top Microbiol Immunol 2009; 332:13 - 31; http://dx.doi.org/10.1007/978-3-540-70868-1_2; PMID: 19401819
   PubMed Web of Science ®Google Scholar
• Smith ML, Lindbo JA, Dillard-Telm S, Brosio PM, Lasnik AB, McCormick AA, Nguyen LV, Palmer KE. Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications. Virology 2006; 348:475 - 88; http://dx.doi.org/10.1016/j.virol.2005.12.039; PMID: 16466765
   PubMed Web of Science ®Google Scholar
• Gleba Y, Klimyuk V, Marillonnet S. Magnifection--a new platform for expressing recombinant vaccines in plants. Vaccine 2005; 23:2042 - 8; http://dx.doi.org/10.1016/j.vaccine.2005.01.006; PMID: 15755568
   PubMed Web of Science ®Google Scholar
• Gleba Y, Klimyuk V, Marillonnet S. Viral vectors for the expression of proteins in plants. Curr Opin Biotechnol 2007; 18:134 - 41; http://dx.doi.org/10.1016/j.copbio.2007.03.002; PMID: 17368018
   PubMed Web of Science ®Google Scholar
• Gleba YY, Tusé D, Giritch A. Plant viral vectors for delivery by agrobacterium. Curr Top Microbiol Immunol 2014; 375:155 - 92; PMID: 23949286
   PubMed Web of Science ®Google Scholar
• Palmer KE, Benko A, Doucette SA, Cameron TI, Foster T, Hanley KM, McCormick AA, McCulloch M, Pogue GP, Smith ML, et al. Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes. Vaccine 2006; 24:5516 - 25; http://dx.doi.org/10.1016/j.vaccine.2006.04.058; PMID: 16725236
   PubMed Web of Science ®Google Scholar
• Mason HS, Lam DM, Arntzen CJ. Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci U S A 1992; 89:11745 - 9; http://dx.doi.org/10.1073/pnas.89.24.11745; PMID: 1465391
   PubMed Web of Science ®Google Scholar
• Mason HS, Haq TA, Clements JD, Arntzen CJ. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine 1998; 16:1336 - 43; http://dx.doi.org/10.1016/S0264-410X(98)80020-0; PMID: 9682399
   PubMed Web of Science ®Google Scholar
• Yusibov V, Modelska A, Steplewski K, Agadjanyan M, Weiner D, Hooper DC, Koprowski H. Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc Natl Acad Sci U S A 1997; 94:5784 - 8; http://dx.doi.org/10.1073/pnas.94.11.5784; PMID: 9159151
   PubMed Web of Science ®Google Scholar
• Yusibov V, Shivprasad S, Turpen TH, Dawson W, Koprowski H. Plant viral vectors based on tobamoviruses. Curr Top Microbiol Immunol 1999; 240:81 - 94; PMID: 10394716
   PubMed Web of Science ®Google Scholar
• Pogue GP, Lindbo JA, Garger SJ, Fitzmaurice WP. Making an ally from an enemy: plant virology and the new agriculture. Annu Rev Phytopathol 2002; 40:45 - 74; http://dx.doi.org/10.1146/annurev.phyto.40.021102.150133; PMID: 12147754
   PubMed Web of Science ®Google Scholar
• Rybicki EP. Plant-made vaccines for humans and animals. Plant Biotechnol J 2010; 8:620 - 37; http://dx.doi.org/10.1111/j.1467-7652.2010.00507.x; PMID: 20233333
   PubMed Web of Science ®Google Scholar
• Paul M, van Dolleweerd C, Drake PM, Reljic R, Thangaraj H, Barbi T, Stylianou E, Pepponi I, Both L, Hehle V, et al. Molecular Pharming: future targets and aspirations. Hum Vaccin 2011; 7:375 - 82; http://dx.doi.org/10.4161/hv.7.3.14456; PMID: 21368584
   PubMed Web of Science ®Google Scholar
• Klimyuk V, Pogue G, Herz S, Butler J, Haydon H. Production of Recombinant Antigens and Antibodies in Nicotiana benthamiana Using ‘Magnifection’ Technology: GMP-Compliant Facilities for Small- and Large-Scale Manufacturing. Curr Top Microbiol Immunol 2014; 375:127 - 54; PMID: 22527176
   PubMed Web of Science ®Google Scholar
• Mett V, Musiychuk K, Bi H, Farrance CE, Horsey A, Ugulava N, Shoji Y, de la Rosa P, Palmer GA, Rabindran S, et al. A plant-produced influenza subunit vaccine protects ferrets against virus challenge. Influenza Other Respir Viruses 2008; 2:33 - 40; http://dx.doi.org/10.1111/j.1750-2659.2008.00037.x; PMID: 19453491
   PubMed Web of Science ®Google Scholar
• Morhard R, Bouri N, Gilles K, Rambhia KJ, Ravi SJ, Sell TK, Watson M. HHS Releases New Strategy for Emergency Medical Countermeasures Enterprise. Biosecur Bioterror 2012; 10:247 - 54; PMID: 22967169
   PubMed Web of Science ®Google Scholar
• Shoji Y, Jones RM, Mett V, Chichester JA, Musiychuk K, Sun X, Tumpey TM, Green BJ, Shamloul M, Norikane J, et al. A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge. Hum Vaccin Immunother 2013; 9:9; http://dx.doi.org/10.4161/hv.23234; PMID: 23296194
   PubMed Web of Science ®Google Scholar
• Wei CJ, Xu L, Kong WP, Shi W, Canis K, Stevens J, Yang ZY, Dell A, Haslam SM, Wilson IA, et al. Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. J Virol 2008; 82:6200 - 8; http://dx.doi.org/10.1128/JVI.00187-08; PMID: 18417563
   PubMed Web of Science ®Google Scholar
• Vanlandschoot P, Beirnaert E, Neirynck S, Saelens X, Jou WM, Fiers W. Molecular and immunological characterization of soluble aggregated A/Victoria/3/75 (H3N2) influenza haemagglutinin expressed in insect cells. Arch Virol 1996; 141:1715 - 26; http://dx.doi.org/10.1007/BF01718294; PMID: 8893793
   PubMed Web of Science ®Google Scholar
• Kemnade JO, Seethammagari M, Collinson-Pautz M, Kaur H, Spencer DM, McCormick AA. Tobacco Mosaic Virus Efficiently Targets DC uptake, Activation and Antigen-specific T Cell Responses in vivo. Vaccine 2013; Submitted
   Google Scholar
• Liu R, Vaishnav RA, Roberts AM, Friedland RP. Humans have antibodies against a plant virus: evidence from tobacco mosaic virus. PLoS One 2013; 8:e60621; http://dx.doi.org/10.1371/journal.pone.0060621; PMID: 23573274
   PubMed Web of Science ®Google Scholar
• Hermanson G. Bioconjugate Techniques. Elsevier, 2008.
   Google Scholar
• McCormick AA, Kumagai MH, Hanley K, Turpen TH, Hakim I, Grill LK, Tusé D, Levy S, Levy R. Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants. Proc Natl Acad Sci U S A 1999; 96:703 - 8; http://dx.doi.org/10.1073/pnas.96.2.703; PMID: 9892697
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. Am J Transplant 2011; 11:2250 - 5; http://dx.doi.org/10.1111/j.1600-6143.2011.03793.x; PMID: 21957937
   PubMed Web of Science ®Google Scholar
• Saveyn H, De Baets B, Thas O, Hole P, Smith J, Van der Meeren P. Accurate particle size distribution determination by nanoparticle tracking analysis based on 2-D Brownian dynamics simulation. J Colloid Interface Sci 2010; 352:593 - 600; http://dx.doi.org/10.1016/j.jcis.2010.09.006; PMID: 20887997
   PubMed Web of Science ®Google Scholar
• Pizzi M. Sampling variation of the fifty percent end-point, determined by the Reed-Muench (Behrens) method. Hum Biol 1950; 22:151 - 90; PMID: 14778593
   PubMedGoogle Scholar